These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 33254074

  • 1. A novel BAFF antagonist, BAFF-Trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL/lpr mice.
    Yu C, Chen S, Zhou B, Zhang H, Su X, Luo Y, Yang L.
    Mol Immunol; 2021 Jan; 129():1-11. PubMed ID: 33254074
    [Abstract] [Full Text] [Related]

  • 2. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
    Zhou L, Sun L, Wu H, Zhang L, Chen M, Liu J, Zhong R.
    Eur J Pharmacol; 2013 Sep 05; 715(1-3):230-7. PubMed ID: 23712004
    [Abstract] [Full Text] [Related]

  • 3. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC, Ortíz-Lazareno P, Marín-Rosales M, Cruz A, Muñoz-Valle F, Tapia-Llanos R, Orozco-Barocio G, Machado-Contreras R, Palafox-Sánchez CA.
    Cytokine; 2019 Feb 05; 114():115-127. PubMed ID: 30467093
    [Abstract] [Full Text] [Related]

  • 4. A benzenediamine derivate FC-99 attenuates lupus nephritis in MRL/lpr mice via inhibiting myeloid dendritic cell-secreted BAFF.
    Ji J, Xu J, Li F, Li X, Gong W, Song Y, Dou H, Hou Y.
    Acta Biochim Biophys Sin (Shanghai); 2016 May 05; 48(5):411-9. PubMed ID: 27121231
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. KR33426, [2-(2,5-dichlorophenyl)-5-methyloxazol-4yl]carbonylguanidine, is a novel compound to be effective on mouse systemic lupus erythematosus.
    Lee GH, Oh JM, Kim HS, Yoon WK, Yi KY, Yang Y, Han SH, Lee S, Moon EY.
    Eur J Pharmacol; 2011 Oct 15; 668(3):459-66. PubMed ID: 21827747
    [Abstract] [Full Text] [Related]

  • 8. Investigations of a rabbit (Oryctolagus cuniculus) model of systemic lupus erythematosus (SLE), BAFF and its receptors.
    Yang J, Pospisil R, Ray S, Milton J, Mage RG.
    PLoS One; 2009 Dec 30; 4(12):e8494. PubMed ID: 20041151
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus.
    Saidoune F, Even G, Lamri Y, Chezel J, Gaston AT, Escoubet B, Papo T, Charles N, Nicoletti A, Sacre K.
    Arthritis Rheumatol; 2021 Feb 30; 73(2):255-264. PubMed ID: 32783382
    [Abstract] [Full Text] [Related]

  • 11. Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.
    Ju ZL, Shi GY, Zuo JX, Zhang JW, Jian Sun.
    Immunology; 2007 Feb 30; 120(2):281-9. PubMed ID: 17073941
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Delayed onset of autoreactive antibody production and M2-skewed macrophages contribute to improved survival of TACI deficient MRL-Fas/Lpr mouse.
    Liu L, Allman WR, Coleman AS, Takeda K, Lin TL, Akkoyunlu M.
    Sci Rep; 2018 Jan 22; 8(1):1308. PubMed ID: 29358664
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus.
    Dong G, Yang Y, Li X, Yao X, Zhu Y, Zhang H, Wang H, Ma Q, Zhang J, Shi H, Ning Z, Yan F, Zhai W, Dai J, Li Z, Li C, Ming J, Xue Q, Meng X, Si C, Xiong H.
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan 01; 1866(1):165554. PubMed ID: 31513833
    [Abstract] [Full Text] [Related]

  • 16. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
    Arkatkar T, Jacobs HM, Du SW, Li QZ, Hudkins KL, Alpers CE, Rawlings DJ, Jackson SW.
    Kidney Int; 2018 Oct 01; 94(4):728-740. PubMed ID: 29907458
    [Abstract] [Full Text] [Related]

  • 17. Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells.
    Du SW, Jacobs HM, Arkatkar T, Rawlings DJ, Jackson SW.
    J Immunol; 2018 Dec 01; 201(11):3258-3268. PubMed ID: 30373855
    [Abstract] [Full Text] [Related]

  • 18. DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
    Lenert P, Yasuda K, Busconi L, Nelson P, Fleenor C, Ratnabalasuriar RS, Nagy PL, Ashman RF, Rifkin IR, Marshak-Rothstein A.
    Arthritis Res Ther; 2009 Dec 01; 11(3):R79. PubMed ID: 19476613
    [Abstract] [Full Text] [Related]

  • 19. A novel modality of BAFF-specific inhibitor AMG623 peptibody reduces B-cell number and improves outcomes in murine models of autoimmune disease.
    Hsu H, Khare SD, Lee F, Miner K, Hu YL, Stolina M, Hawkins N, Chen Q, Ho SY, Min H, Xiong F, Boone T, Zack DJ.
    Clin Exp Rheumatol; 2012 Dec 01; 30(2):197-201. PubMed ID: 22325420
    [Abstract] [Full Text] [Related]

  • 20. Renal tubular epithelial cell-derived BAFF expression mediates kidney damage and correlates with activity of proliferative lupus nephritis in mouse and men.
    Schwarting A, Relle M, Meineck M, Föhr B, Triantafyllias K, Weinmann A, Roth W, Weinmann-Menke J.
    Lupus; 2018 Feb 01; 27(2):243-256. PubMed ID: 28659046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.